Minocycline to Treat Childhood Regressive Autism

Academy Sites Books Clinical CME E-mail Journals Links Medline Parents Pharmaceuticals Professional Research Teaching Web Portals Internet Course

Principal Investigator:  David Neville, MD and Susan Swedo, MD

Brief Description:   

The purpose of this study is to see if the administration of minocycline will be helpful to children with regressive autism (autism with a history of loss of social and/or language skills). Minocycline is an antibiotic and will be taken orally in this study. It is FDA-approved for the treatment of a variety of infections and has been shown to improve brain inflammation in at least one neurological disorder. Minocycline’s anti-inflammatory properties may be beneficial in autism and may improve autistic symptoms.

Contact Information: 
Carrie Masur, Research Assistant
Call:   301-435-7962
Email:  nimh-asd@mail.nih.gov


This study is approved by our IRB as Protocol # 07-M-0024

Go back to Child-Neuro Homepage

Go back to Seeking Patients page

Last revised 07-Feb-2007 by Steven Leber